Citation:Shepherd FA, Giaccone G, Seymour L, Debruyne C, Bezjak A, Hirsh V, et al 2002

From Cancer Guidelines Wiki

Citation


Shepherd FA, Giaccone G, Seymour L, Debruyne C, Bezjak A, Hirsh V, et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002 Nov 15;20(22):4434-9 Abstract available at HTTP://WWW.NCBI.NLM.NIH.GOV/PUBMED/12431965.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal chemotherapy regimen and duration of therapy in extensive stage small cell lung cancer in the first-line setting?Associate Professor Michael Michael MBBS(Hons), BSc(Hons), MD, FRACPcompleted

Compare quality appraisals for each clinical question

Cited by

  1. What is the optimal systemic therapy and duration to be used for the treatment of limited stage small cell lung cancer?